Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis

Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis

(2017) Tuncay Gündüz et al.   Multiple Sclerosis and Related Disorders

Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning

(2016) Vittorio Martinelli et al.   Multiple Sclerosis Journal

Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment

(2016) Stacy Ellen Hatcher et al.   JAMA Neurology

Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning

(2016) Vittorio Martinelli et al.   Multiple Sclerosis Journal

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

(2014) G. Karlsson et al.   NEUROLOGY

Management of Multiple Sclerosis During Pregnancy and the Reproductive Years

(2014) Riley Bove et al.   OBSTETRICS AND GYNECOLOGY

Natalizumab Use During the Third Trimester of Pregnancy

(2014) Aiden Haghikia et al.   JAMA Neurology

Rebound of disease activity during pregnancy after withdrawal of fingolimod

(2013) A. P. Sempere et al.   EUROPEAN JOURNAL OF NEUROLOGY

Rebound of Disease Activity After Withdrawal of Fingolimod (FTY720) Treatment

(2012) Joachim B. Havla   ARCHIVES OF NEUROLOGY